Exclusive Content
How AstraZeneca Built a R&D Center in China: Market Entry Case Study
How AstraZeneca Built a R&D Center in China: Market Entry Case Study How AstraZeneca Built a R&D Center in China: Market Entry Case Study AstraZeneca'
How to Certify Electrical Products for China: CCC Compliance Guide
How to Certify Electrical Products for China: CCC Compliance Guide for Foreign Brands body{font-family:Arial,Helvetica,sans-serif;line-height:1.8;colo
How Pfizer Got 5 New Drugs Approved in China: Pharma Case Study
How Pfizer Got 5 New Drugs Approved in China: Pharma Case Study In 2023, Pfizer secured China approval for 5 innovative drugs—a 40% increase over its
Greenfield vs Joint Venture: Which Market Entry Model for Foreign Pharma in China?
Greenfield vs Joint Venture: Which Market Entry Model for Foreign Pharma in China? Over 60% of foreign pharmaceutical companies entering China between
In-House vs Outsourced Clinical Trials: Which CRO Strategy in China?
In-House vs Outsourced Clinical Trials: Which CRO Strategy in China? China’s clinical trial market surpassed ¥46 billion (≈$6.5 billion) in 2023, grow
NMPA Fast Track vs Standard Review: Which Drug Approval Pathway in China?
NMPA Fast Track vs Standard Review: Which Drug Approval Pathway in China? In 2024, the NMPA approved 83 new drugs, with 58% (48 drugs) utilizing fast